Collectively, these results indicated an intimate interdependence between MEF2D fusion and the PI3K/AKT signaling pathway, with activated pathways playing a critical role in MEF2D fusion BCP-ALL pathogenesis. The gene discussed is PIK3CB; the disease is acute lymphoblastic leukemia.